| For: | Chen F, Wang T, Wu YF, Gu Y, Xu XL, Zheng S, Hu X. Honokiol: A potent chemotherapy candidate for human colorectal carcinoma. World J Gastroenterol 2004; 10(23): 3459-3463 [PMID: 15526365 DOI: 10.3748/wjg.v10.i23.3459] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i23/3459.htm |
| Number | Citing Articles |
| 1 |
Ju Hoon Oh, Jung Ok Ban, Min-Chul Cho, Miran Jo, Jae Kyung Jung, Byeongwoo Ahn, Do-Young Yoon, Sang Bae Han, Jin Tae Hong. 4-O-methylhonokiol inhibits colon tumor growth via p21-mediated suppression of NF-κB activity. The Journal of Nutritional Biochemistry 2012; 23(7) doi: 10.1016/j.jnutbio.2011.03.013
|
| 2 |
Natural Products and Cancer Signaling: Isoprenoids, Polyphenols and Flavonoids. The Enzymes 2014; 36 doi: 10.1016/B978-0-12-802215-3.00009-4
|
| 3 |
Azar Aghamohammadi, Seyed Jalal Hosseinimehr. Antiangiogenic Agents in Natural Products for the Treatment of Gynecologic Disorders. Nutrition and Cancer 2014; 66(2) doi: 10.1080/01635581.2014.865136
|
| 4 |
Zhiyun He, Dharmalingam Subramaniam, Satish Ramalingam, Animesh Dhar, Russell G. Postier, Shahid Umar, Youcheng Zhang, Shrikant Anant. Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects. American Journal of Physiology-Gastrointestinal and Liver Physiology 2011; 301(5) doi: 10.1152/ajpgi.00159.2011
|
| 5 |
Katsumi Shigemura, Jack L. Arbiser, Shi‐Yong Sun, Majd Zayzafoon, Peter A.S. Johnstone, Masato Fujisawa, Akinobu Gotoh, Babette Weksler, Haiyen E. Zhau, Leland W.K. Chung. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer 2007; 109(7) doi: 10.1002/cncr.22551
|
| 6 |
Mahmood Bahmani, Hedayatollah Shirzad, Najmeh Shahinfard, Laaleh Sheivandi, Mahmoud Rafieian-Kopaei. Cancer Phytotherapy. Journal of Evidence-Based Complementary & Alternative Medicine 2017; 22(2) doi: 10.1177/2156587215625157
|
| 7 |
Michael McCulloch, Helen Ly, Michael Broffman, Caylie See, Jen Clemons, Raymond Chang. Chinese Herbal Medicine and Fluorouracil-Based Chemotherapy for Colorectal Cancer. Integrative Cancer Therapies 2016; 15(3) doi: 10.1177/1534735416638738
|
| 8 |
Chih-Yeu Fang, Siang-Jyun Chen, Huey-Nan Wu, Yueh-Hsin Ping, Ching-Yen Lin, David Shiuan, Chi-Long Chen, Ying-Ray Lee, Kao-Jean Huang. Honokiol, a Lignan Biphenol Derived from the Magnolia Tree, Inhibits Dengue Virus Type 2 Infection. Viruses 2015; 7(9) doi: 10.3390/v7092852
|
| 9 |
Ankit Kumar, Umesh Kumar Singh, Anurag Chaudhary. Honokiol Analogs: A Novel Class of Anticancer Agents Targeting Cell Signaling Pathways and Other Bioactivities. Future Medicinal Chemistry 2013; 5(7) doi: 10.4155/fmc.13.32
|
| 10 |
Chunhua Yu, Qiuyang Zhang, Hui Ying Zhang, Xi Zhang, Xiaofang Huo, Edaire Cheng, David H. Wang, Jack L. Arbiser, Stuart Jon Spechler, Rhonda F. Souza. Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 303(5) doi: 10.1152/ajpgi.00033.2012
|
| 11 |
Wenli Hou, Lijuan Chen, Guangli Yang, Hang Zhou, Qiqi Jiang, Zhenhua Zhong, Jia Hu, Xiang Chen, Xianhuo Wang, Yuan Yuan, Minghai Tang, Jing Wen, Yuquan Wei. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models. Phytotherapy Research 2008; 22(8) doi: 10.1002/ptr.2472
|
| 12 |
Jia Hu, Li-juan Chen, Li Liu, Xiang Chen, Ping Chen, Guang-li Yang, Wen-li Hou, Ming-hai Tang, Fan Zhang, Xian-huo Wang, Xia Zhao, Yu-quan Wei. Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity. Experimental and Molecular Medicine 2008; 40(6) doi: 10.3858/emm.2008.40.6.617
|
| 13 |
Anfernee Kai-Wing Tse, Chi-Keung Wan, Xiao-Ling Shen, Mengsu Yang, Wang-Fun Fong. Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB-regulated gene expression through suppression of IKK activation. Biochemical Pharmacology 2005; 70(10) doi: 10.1016/j.bcp.2005.08.011
|
| 14 |
Jiexiang Yang, Yonggen Zou, Dianmin Jiang. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3433
|
| 15 |
Yang Wang, Ru-Yuan Yu, Qing-Yu He. Proteomic Analysis of Anticancer TCMs Targeted at Mitochondria. Evidence-Based Complementary and Alternative Medicine 2015; 2015 doi: 10.1155/2015/539260
|
| 16 |
Daniel G. Vassão, Kye-Won Kim, Laurence B. Davin, Norman G. Lewis. Comprehensive Natural Products II. 2010; doi: 10.1016/B978-008045382-8.00001-0
|
| 17 |
Abhishek Ranaware, Kishore Banik, Vishwas Deshpande, Ganesan Padmavathi, Nand Roy, Gautam Sethi, Lu Fan, Alan Kumar, Ajaikumar Kunnumakkara. Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer. International Journal of Molecular Sciences 2018; 19(8) doi: 10.3390/ijms19082362
|
| 18 |
Ruth Guillermo-Lagae, Sreevidya Santha, Milton Thomas, Emily Zoelle, Jonathan Stevens, Radhey S. Kaushik, Chandradhar Dwivedi. Antineoplastic Effects of Honokiol on Melanoma. BioMed Research International 2017; 2017 doi: 10.1155/2017/5496398
|
| 19 |
|
| 20 |
Yinfeng Dong, Minghai Tang, Hang Song, Rong Li, Chunyu Wang, Haoyu Ye, Neng Qiu, Yongkui Zhang, Lijuan Chen, Yuquan Wei. Characterization of metabolic profile of honokiol in rat feces using liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry and 13C stable isotope labeling. Journal of Chromatography B 2014; doi: 10.1016/j.jchromb.2014.01.047
|
| 21 |
Chandeshwari Chilampalli, Ruth Guillermo, Radhey S Kaushik, Alan Young, Gudiseva Chandrasekher, Hesham Fahmy, Chandradhar Dwivedi. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells. Experimental Biology and Medicine 2011; 236(11) doi: 10.1258/ebm.2011.011030
|
| 22 |
A. S. Prakasha Gowda, Zucai Suo, Thomas E. Spratt. Honokiol Inhibits DNA Polymerases β and λ and Increases Bleomycin Sensitivity of Human Cancer Cells. Chemical Research in Toxicology 2017; 30(2) doi: 10.1021/acs.chemrestox.6b00451
|
| 23 |
Andrey V. Shubin, Ilya V. Demidyuk, Alexey A. Komissarov, Lola M. Rafieva, Sergey V. Kostrov. Cytoplasmic vacuolization in cell death and survival. Oncotarget 2016; 7(34) doi: 10.18632/oncotarget.10150
|
| 24 |
Geng Pan, Chao Liang, Dan Staerk, Lars P. Christensen, Stig M. Thamsborg, Tina V. A. Hansen, Andrew R. Williams. Magnolol and Honokiol Are Novel Antiparasitic Compounds from Magnolia officinalis That Target the Mitochondrial Electron Transport Chain. ACS Omega 2025; 10(39) doi: 10.1021/acsomega.5c06232
|
| 25 |
Aleksandra Mędra, Magdalena Witkowska, Agata Majchrzak, Barbara Cebula-Obrzut, Michael Bonner, Tadeusz Robak, Jack Arbiser, Piotr Smolewski. Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies. Molecules 2016; 21(8) doi: 10.3390/molecules21080995
|
| 26 |
Eun‐Ryeong Hahm, A. Isabella Karlsson, Michael Y. Bonner, Jack L. Arbiser, Shivendra V. Singh. Honokiol inhibits androgen receptor activity in prostate cancer cells. The Prostate 2014; 74(4) doi: 10.1002/pros.22762
|
| 27 |
Jing Pan, Yongik Lee, Qi Zhang, Donghai Xiong, Tina C. Wan, Yian Wang, Ming You. Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway. Cancer Prevention Research 2017; 10(2) doi: 10.1158/1940-6207.CAPR-16-0129
|
| 28 |
Kao‐Jean Huang, Chin‐Ho Kuo, Shu‐Hsin Chen, Ching‐Yen Lin, Ying‐Ray Lee. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy. Journal of Cellular and Molecular Medicine 2018; 22(3) doi: 10.1111/jcmm.13474
|
| 29 |
Gang Chen, Feng Wang, Dunyaporn Trachootham, Peng Huang. Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion 2010; 10(6) doi: 10.1016/j.mito.2010.08.001
|
| 30 |
Tripti Singh, Santosh K. Katiyar, Xianglin Shi. Honokiol Inhibits Non-Small Cell Lung Cancer Cell Migration by Targeting PGE2-Mediated Activation of β-Catenin Signaling. PLoS ONE 2013; 8(4) doi: 10.1371/journal.pone.0060749
|
| 31 |
Chia-Hsien Chen, Chang-Jung Chiang, Lien-Chen Wu, Chih-Hong Yang, Yi-Jie Kuo, Tung-Hu Tsai. In vitro Penetration and in vivo Distribution of Honokiol into the Intervertebral Disc in Rat. Analytical Sciences 2015; 31(12) doi: 10.2116/analsci.31.1297
|
| 32 |
Parteek Prasher, Rabab Fatima, Mousmee Sharma, Bekzat Tynybekov, Asma M. Alshahrani, Dilek Arslan Ateşşahin, Javad Sharifi-Rad, Daniela Calina. Honokiol and its analogues as anticancer compounds: Current mechanistic insights and structure-activity relationship. Chemico-Biological Interactions 2023; 386 doi: 10.1016/j.cbi.2023.110747
|
| 33 |
WEI TIAN, YONGCHUAN DENG, LING LI, HAIFEI HE, JIE SUN, DONG XU. Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death. International Journal of Oncology 2013; 42(2) doi: 10.3892/ijo.2012.1739
|
| 34 |
Gaurav Kaushik, Deep Kwatra, Dharmalingam Subramaniam, Roy A. Jensen, Shrikant Anant, Joshua M.V. Mammen. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway. The American Journal of Surgery 2014; 208(6) doi: 10.1016/j.amjsurg.2014.09.014
|
| 35 |
Ding Lin, Zhongzhong Yan, Aiyu Chen, Jiao Ye, Aixi Hu, Juan Liu, Junmei Peng, Xiaoyun Wu. Anti-proliferative activity and structure-activity relationship of honokiol derivatives. Bioorganic & Medicinal Chemistry 2019; 27(16) doi: 10.1016/j.bmc.2019.06.042
|
| 36 |
Traci E. Battle, Jack Arbiser, David A. Frank. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 2005; 106(2) doi: 10.1182/blood-2004-11-4273
|
| 37 |
Xiaodong Shi, Langsheng Yang, Jihai Gao, Yuzhen Sheng, Xiaoqing Li, Yunjie Gu, Guoqing Zhuang, Fang Chen. Deep sequencing of Magnoliae officinalis reveals upstream genes related to the lignan biosynthetic pathway. Journal of Forestry Research 2017; 28(4) doi: 10.1007/s11676-016-0356-5
|
| 38 |
Ling Li, Weidong Han, Ying Gu, Shuang Qiu, Qinghua Lu, Jie Jin, Jianhong Luo, Xun Hu. Honokiol Induces a Necrotic Cell Death through the Mitochondrial Permeability Transition Pore. Cancer Research 2007; 67(10) doi: 10.1158/0008-5472.CAN-06-3818
|
| 39 |
Chih-Jung Yao, Gi-Ming Lai, Chi-Tai Yeh, Ming-Tang Lai, Ping-Hsiao Shih, Wan-Ju Chao, Jacqueline Whang-Peng, Shuang-En Chuang, Tung-Yuan Lai. Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/β-Catenin Signaling and Apoptosis Induction. Evidence-Based Complementary and Alternative Medicine 2013; 2013 doi: 10.1155/2013/146136
|
| 40 |
Keng-li Lan, Keng-hsin Lan, Meei-ling Sheu, Ming-yuan Chen, Yi-sheng Shih, Fu-chih Hsu, Hong-Ming Wang, Ren-shyan Liu, Sang-hue Yen. Honokiol inhibits hypoxia-inducible factor-1 pathway. International Journal of Radiation Biology 2011; 87(6) doi: 10.3109/09553002.2011.568572
|
| 41 |
JUNG-IL CHAE, YOUNG-JOO JEON, JUNG-HYUN SHIM. Downregulation of Sp1 is involved in honokiol-induced cell cycle arrest and apoptosis in human malignant pleural mesothelioma cells. Oncology Reports 2013; 29(6) doi: 10.3892/or.2013.2353
|
| 42 |
Zhu Yuan, Huanyi Liu, Fei Yan, Yongsheng Wang, Lantu Gou, Chunlai Nie, Zhenyu Ding, Songtao Lai, Yuwei Zhao, Xinyu Zhao, Jiong Li, Hongxin Deng, Yongqiu Mao, Lijuan Chen, Yuquan Wei, Xia Zhao. Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS‐4, a novel pro‐apoptotic gene. Cancer Science 2009; 100(9) doi: 10.1111/j.1349-7006.2009.01242.x
|
| 43 |
Haixia Ji, Ou Qiao, Yi Zhang, Wenzhe Wang, Xiaoyin Han, Xinyu Zhang, Changxiao Liu, Wenyuan Gao. Dual targeting of wild‐type p53 and gut microbiota by Magnolol represses key metabolic process and kills CRC cells. Phytotherapy Research 2024; 38(10) doi: 10.1002/ptr.7924
|
| 44 |
Tripti Singh, Ram Prasad, Santosh K. Katiyar. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo. Epigenetics 2013; 8(1) doi: 10.4161/epi.23078
|
| 45 |
Mohanad Zbidah, Adrian Lupescu, Tabea Herrmann, Wenting Yang, Michael Foller, Kashif Jilani, Florian Lang. Effect of honokiol on erythrocytes. Toxicology in Vitro 2013; 27(6) doi: 10.1016/j.tiv.2013.05.003
|
| 46 |
NJ Lee, JH Oh, JO Ban, JH Shim, HP Lee, JK Jung, BW Ahn, DY Yoon, SB Han, YW Ham, JT Hong. 4‐O‐methylhonokiol, aPPARγagonist, inhibits prostate tumour growth: p21‐mediated suppression ofNF‐κBactivity. British Journal of Pharmacology 2013; 168(5) doi: 10.1111/j.1476-5381.2012.02235.x
|
| 47 |
Tianyu Wang, Hui Wang, Fan Yang, Kuan Gao, Shuya Luo, Lichuan Bai, Ke Ma, Mei Liu, Shuwei Wu, Huijie Wang, Zaixing Chen, Qinghuan Xiao. Honokiol inhibits proliferation of colorectal cancer cells by targeting anoctamin 1/TMEM16A Ca2+‐activated Cl− channels. British Journal of Pharmacology 2021; 178(20) doi: 10.1111/bph.15606
|
| 48 |
Min Suk Seo, Jung Hwan Kim, Hye Jung Kim, Ki Churl Chang, Sang Won Park. Honokiol activates the LKB1–AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes. Toxicology and Applied Pharmacology 2015; 284(2) doi: 10.1016/j.taap.2015.02.020
|
| 49 |
Yasmeen Ezzeldeen, Shady Swidan, Aliaa ElMeshad, Aya Sebak. Green Synthesized Honokiol Transfersomes Relieve the Immunosuppressive and Stem-Like Cell Characteristics of the Aggressive B16F10 Melanoma. International Journal of Nanomedicine 2021; doi: 10.2147/IJN.S314472
|
| 50 |
Huanli Xu, Wei Tang, Guanhua Du, Norihiro Kokudo. Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of <i>Magnolia officinalis </i>. Drug Discoveries & Therapeutics 2011; 5(5) doi: 10.5582/ddt.2011.v5.5.202
|
| 51 |
So Yong Lee, Dong Yeon Yuk, Ho Seub Song, Do Young Yoon, Jae Kyung Jung, Dong Cheul Moon, Byung Seok Lee, Jin Tae Hong. Growth inhibitory effects of obovatol through induction of apoptotic cell death in prostate and colon cancer by blocking of NF-κB. European Journal of Pharmacology 2008; 582(1-3) doi: 10.1016/j.ejphar.2007.12.027
|
| 52 |
Ling-Li Han, Li-Ping Xie, Ling-Hui Li, Xiao-Wen Zhang, Rong-Qing Zhang, Hong-Zhong Wang. Reactive oxygen species production and Bax/Bcl-2 regulation in honokiol-induced apoptosis in human hepatocellular carcinoma SMMC-7721 cells. Environmental Toxicology and Pharmacology 2009; 28(1) doi: 10.1016/j.etap.2009.03.005
|
| 53 |
Eun-Ryeong Hahm, Shivendra V. Singh. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Molecular Cancer Therapeutics 2007; 6(10) doi: 10.1158/1535-7163.MCT-07-0217
|
| 54 |
Chie Ishikawa, Jack L. Arbiser, Naoki Mori. Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia. Biochimica et Biophysica Acta (BBA) - General Subjects 2012; 1820(7) doi: 10.1016/j.bbagen.2012.03.009
|
| 55 |
Shruti M. Raja, Shuzhen Chen, Ping Yue, Timothy M. Acker, Benjamin Lefkove, Jack L. Arbiser, Fadlo R. Khuri, Shi-Yong Sun. The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor–induced apoptosis. Molecular Cancer Therapeutics 2008; 7(7) doi: 10.1158/1535-7163.MCT-07-2409
|
| 56 |
Donald R. Yance, Stephen M. Sagar. Targeting Angiogenesis With Integrative Cancer Therapies. Integrative Cancer Therapies 2006; 5(1) doi: 10.1177/1534735405285562
|
| 57 |
Eun-Ryeong Hahm, Kozue Sakao, Shivendra V. Singh. Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells. The Prostate 2014; 74(12) doi: 10.1002/pros.22837
|
| 58 |
Patrick Steinmann, Denise K. Walters, Matthias J. E. Arlt, Ingo J. Banke, Urs Ziegler, Bettina Langsam, Jack Arbiser, Roman Muff, Walter Born, Bruno Fuchs. Antimetastatic activity of honokiol in osteosarcoma. Cancer 2012; 118(8) doi: 10.1002/cncr.26434
|
| 59 |
Md. Faysal, Jishan Khan, Mehrukh Zehravi, Nikhil Nath, Laliteshwar Pratap Singh, Saloni Kakkar, Rajashekar Perusomula, Pathan Amanulla Khan, Firzan Nainu, Mohammed Asiri, Sharuk L. Khan, Rajib Das, Talha Bin Emran, Polrat Wilairatana. Neuropharmacological potential of honokiol and its derivatives from Chinese herb Magnolia species: understandings from therapeutic viewpoint. Chinese Medicine 2023; 18(1) doi: 10.1186/s13020-023-00846-1
|
| 60 |
Ekaterina I. Mikhaevich, Danila V. Sorokin, Alexander M. Scherbakov. Honokiol inhibits the growth of hormone-resistant breast cancer cells: its promising effect in combination with metformin. Research in Pharmaceutical Sciences 2023; 18(5) doi: 10.4103/1735-5362.383712
|
| 61 |
Fatima Khatoon, Sabeeha Ali, Vijay Kumar, Abdelbaset Mohamed Elasbali, Hassan H. Alhassan, Salem Hussain Alharethi, Asimul Islam, Md. Imtaiyaz Hassan. Pharmacological features, health benefits and clinical implications of honokiol. Journal of Biomolecular Structure and Dynamics 2023; 41(15) doi: 10.1080/07391102.2022.2120541
|
| 62 |
Pengkai Sun, Bin Wang, Caiyun Liu, Zixiong Wang, Yang Liu, Yuan-Biao Qiao, Xinjian Li. A fluorescent STING ligand sensor for high-throughput screening of compounds that can enhance tumor immunotherapy. Cell Reports Methods 2025; 5(7) doi: 10.1016/j.crmeth.2025.101106
|
| 63 |
Aliaa M. Mohassab, Heba A. Hassan, Dalia Abdelhamid, Mohamed Abdel-Aziz. STAT3 transcription factor as target for anti-cancer therapy. Pharmacological Reports 2020; 72(5) doi: 10.1007/s43440-020-00156-5
|
| 64 |
Y. Liu, L. Chen, X. He, L. Fan, G. Yang, X. Chen, X. Lin, L. Du, Z. Li, H. Ye, Y. Mao, X. Zhao, Y. Wei. Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma. International Journal of Gynecological Cancer 2008; 18(4) doi: 10.1136/ijgc-00009577-200807000-00009
|
| 65 |
Eun-Ryeong Hahm, Krishna Beer Singh, Shivendra V. Singh. c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells. Cell Cycle 2016; 15(17) doi: 10.1080/15384101.2016.1201253
|
| 66 |
C.-K. Chiang, M.-L. Sheu, K.-Y. Hung, K.-D. Wu, S.-H. Liu. Honokiol, a small molecular weight natural product, alleviates experimental mesangial proliferative glomerulonephritis. Kidney International 2006; 70(4) doi: 10.1038/sj.ki.5001617
|
| 67 |
Peramaiyan Rajendran, Feng Li, Muthu K. Shanmugam, Shireen Vali, Taher Abbasi, Shweta Kapoor, Kwang Seok Ahn, Alan Prem Kumar, Gautam Sethi. Honokiol inhibits signal transducer and activator of transcription‐3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP‐1. Journal of Cellular Physiology 2012; 227(5) doi: 10.1002/jcp.22954
|
| 68 |
Emma E. Ramsay, Philip J. Hogg, Pierre J. Dilda. Mitochondrial Metabolism Inhibitors for Cancer Therapy. Pharmaceutical Research 2011; 28(11) doi: 10.1007/s11095-011-0584-5
|
| 69 |
Young-Jung Lee, Yoot Mo Lee, Chong-Kil Lee, Jae Kyung Jung, Sang Bae Han, Jin Tae Hong. Therapeutic applications of compounds in the Magnolia family. Pharmacology & Therapeutics 2011; 130(2) doi: 10.1016/j.pharmthera.2011.01.010
|
| 70 |
Pamela Ovadje, Alessia Roma, Matthew Steckle, Leah Nicoletti, John Thor Arnason, Siyaram Pandey. Advances in the Research and Development of Natural Health Products as Main Stream Cancer Therapeutics. Evidence-Based Complementary and Alternative Medicine 2015; 2015 doi: 10.1155/2015/751348
|
| 71 |
Dan Liu, Linjiang Wang, Henan Li, Dong Li, Jianwen Zhou, Jing Wang, Qi Zhang, Defu Cai. Co-Delivery of Gemcitabine and Honokiol by Lipid Bilayer-Coated Mesoporous Silica Nanoparticles Enhances Pancreatic Cancer Therapy via Targeting Depletion of Tumor Stroma. Molecules 2024; 29(3) doi: 10.3390/molecules29030675
|
| 72 |
Rebecca J. Leeman-Neill, Quan Cai, Sonali C. Joyce, Sufi M. Thomas, Neil E. Bhola, Daniel B. Neill, Jack L. Arbiser, Jennifer R. Grandis. Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors. Clinical Cancer Research 2010; 16(9) doi: 10.1158/1078-0432.CCR-10-0333
|
| 73 |
KEN-HU CHANG, MING-DE YAN, CHIH-JUNG YAO, PEI-CHUN LIN, GI-MING LAI. Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells. Oncology Letters 2013; 6(5) doi: 10.3892/ol.2013.1548
|
| 74 |
Wenxia Sun, Cuiting Lv, Tonghan Zhu, Xue Yang, Shanjian Wei, Jieyin Sun, Kui Hong, Weiming Zhu, Caiguo Huang. Ophiobolin-O Reverses Adriamycin Resistance via Cell Cycle Arrest and Apoptosis Sensitization in Adriamycin-Resistant Human Breast Carcinoma (MCF-7/ADR) Cells. Marine Drugs 2013; 11(11) doi: 10.3390/md11114570
|
| 75 |
Dong Xu, Qinghua Lu, Xun Hu. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Letters 2006; 243(2) doi: 10.1016/j.canlet.2005.11.031
|
| 76 |
Zhengyu Li, Yi Liu, Xia Zhao, Xiaoling Pan, Rutie Yin, Canhua Huang, Lijuan Chen, Yuquan Wei. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells. European Journal of Obstetrics & Gynecology and Reproductive Biology 2008; 140(1) doi: 10.1016/j.ejogrb.2008.02.023
|
| 77 |
Mohamed Saeed, Victor Kuete, Onat Kadioglu, Jonas Börtzler, Hassan Khalid, Henry Johannes Greten, Thomas Efferth. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking. Phytomedicine 2014; 21(12) doi: 10.1016/j.phymed.2014.07.011
|
| 78 |
Jing Pan, Yongik Lee, Yian Wang, Ming You. Honokiol targets mitochondria to halt cancer progression and metastasis. Molecular Nutrition & Food Research 2016; 60(6) doi: 10.1002/mnfr.201501007
|
| 79 |
Hanyan Luo, Hongwei Wu, Xiankuo Yu, Xiao Zhang, Yaqi Lu, Jianwei Fan, Liying Tang, Zhuju Wang. A review of the phytochemistry and pharmacological activities of Magnoliae officinalis cortex. Journal of Ethnopharmacology 2019; 236 doi: 10.1016/j.jep.2019.02.041
|
| 80 |
Yi-Ren Chen, Pei-Wen Hsiao, Feng-Ming Lin, Guan-James Wu, Chin-Hsien Tsai. Materia Medica for Various Cancers. Evidence-based Anticancer Complementary and Alternative Medicine 2012; 2 doi: 10.1007/978-94-007-1983-5_6
|
| 81 |
Kangmao Huang, Yanyan Chen, Rui Zhang, Yizheng Wu, Yan Ma, Xiangqian Fang, Shuying Shen. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo. Cell Death & Disease 2018; 9(2) doi: 10.1038/s41419-017-0166-5
|
| 82 |
Stephen M. Sagar, Raimond K. Wong. Supportive Cancer Care with Chinese Medicine. 2010; doi: 10.1007/978-90-481-3555-4_6
|
| 83 |
Sumit Arora, Arun Bhardwaj, Sanjeev K. Srivastava, Seema Singh, Steven McClellan, Bin Wang, Ajay P. Singh, Dhyan Chandra. Honokiol Arrests Cell Cycle, Induces Apoptosis, and Potentiates the Cytotoxic Effect of Gemcitabine in Human Pancreatic Cancer Cells. PLoS ONE 2011; 6(6) doi: 10.1371/journal.pone.0021573
|
| 84 |
Abdur Rauf, Seema Patel, Muhammad Imran, Aneela Maalik, Muhammad Umair Arshad, Farhan Saeed, Yahia N. Mabkhot, Salim S. Al-Showiman, Nazir Ahmad, Eman Elsharkawy. Honokiol: An anticancer lignan. Biomedicine & Pharmacotherapy 2018; 107 doi: 10.1016/j.biopha.2018.08.054
|
| 85 |
Liang Ma, Jinying Chen, Xuewei Wang, Xiaolin Liang, Youfu Luo, Wei Zhu, Tianen Wang, Ming Peng, Shucai Li, Shi Jie, Aihua Peng, Yuquan Wei, Lijuan Chen. Structural Modification of Honokiol, a Biphenyl Occurring in Magnolia officinalis: the Evaluation of Honokiol Analogues as Inhibitors of Angiogenesis and for Their Cytotoxicity and Structure–Activity Relationship. Journal of Medicinal Chemistry 2011; 54(19) doi: 10.1021/jm200830u
|
| 86 |
Hsiu-Chung Ou, Fen-Pi Chou, Tsung-Min Lin, Ching-Hwa Yang, Wayne Huey-Herng Sheu. Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells. Chemico-Biological Interactions 2006; 161(1) doi: 10.1016/j.cbi.2006.02.006
|
| 87 |
Chon Phin Ong, Wai Leong Lee, Yin Quan Tang, Wei Hsum Yap. Honokiol: A Review of Its Anticancer Potential and Mechanisms. Cancers 2019; 12(1) doi: 10.3390/cancers12010048
|
| 88 |
Keng‐Hsin Lan, Ying‐Wen Wang, Wei‐Ping Lee, Keng‐Li Lan, Szu‐Han Tseng, Li‐Rong Hung, Sang‐Hue Yen, Han‐Chieh Lin, Shou‐Dong Lee. Multiple effects of honokiol on the life cycle of hepatitis C virus. Liver International 2012; 32(6) doi: 10.1111/j.1478-3231.2011.02621.x
|
| 89 |
Y. LIU, L. CHEN, X. HE, L. FAN, G. YANG, X. CHEN, X. LIN, L. DU, Z. LI, H. YE, Y. MAO, X. ZHAO, Y. WEI. Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma. International Journal of Gynecological Cancer 2008; 18(4) doi: 10.1111/j.1525-1438.2007.01070.x
|
| 90 |
Martina Grandi, Francesco Boldrin, Giovanni Risato, Silvia Grillini, Natascia Tiso, Francesco Argenton, Emanuela Leonardi, Silvio Tosatto, Giancarlo Solaini, Alessandra Baracca, Valentina Giorgio. Honokiol blocks tumor development and metastasis through mitochondrion-targeted effects. Cell Death & Disease 2026; 17(1) doi: 10.1038/s41419-026-08441-6
|
| 91 |
Hongmei Li, Xianfeng Wang, Yuzhu Hu. Distinct Photoacidity of Honokiol from Magnolol. Journal of Fluorescence 2011; 21(1) doi: 10.1007/s10895-010-0714-1
|
| 92 |
Ling Li, Qinghua Lu, Yanwei Shen, Xun Hu. Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells. Biochemical Pharmacology 2006; 71(5) doi: 10.1016/j.bcp.2005.11.026
|
| 93 |
B. Ling, S.-F. Liang, Y.-H. Xu, X.-Y. Zhao, M.-H. Tang, X.-Y. Liu, X. Zhao, C.-H. Huang, L.-J. Chen, Y.-Q. Wei. Differential proteomic analysis of HeLa cells treated with Honokiol using a quantitative proteomic strategy. Amino Acids 2008; 35(1) doi: 10.1007/s00726-007-0615-z
|
| 94 |
Yinglin Zuo, Yi Yu, Shuni Wang, Weiyan Shao, Binhua Zhou, Li Lin, Zhuoyu Luo, Ruogu Huang, Jun Du, Xianzhang Bu. Synthesis and cytotoxicity evaluation of biaryl-based chalcones and their potential in TNFα-induced nuclear factor-κB activation inhibition. European Journal of Medicinal Chemistry 2012; 50 doi: 10.1016/j.ejmech.2012.02.023
|
| 95 |
Wei-Zhe Liang, Chiang-Ting Chou, Hong-Tai Chang, Jin-Shiung Cheng, Daih-Huang Kuo, Kuang-Chung Ko, Ni-Na Chiang, Ru-Fang Wu, Pochuen Shieh, Chung-Ren Jan. The mechanism of honokiol-induced intracellular Ca2+ rises and apoptosis in human glioblastoma cells. Chemico-Biological Interactions 2014; 221 doi: 10.1016/j.cbi.2014.07.012
|
| 96 |
D. Ainbinder, R. Protokin, M. Chaouat, E. Touitou. Effect of honokiol and 5-FU on non-melanoma skin cancer cells. Journal of Drug Delivery Science and Technology 2009; 19(4) doi: 10.1016/S1773-2247(09)50053-6
|
| 97 |
Xi Dai, Run-Ze Li, Ze-Bo Jiang, Chun-Li Wei, Lian-Xiang Luo, Xiao-Jun Yao, Guo-Ping Li, Elaine L.-H. Leung. Honokiol Inhibits Proliferation, Invasion and Induces Apoptosis Through Targeting Lyn Kinase in Human Lung Adenocarcinoma Cells. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00558
|
| 98 |
Eun-Ryeong Hahm, Julie A. Arlotti, Stanley W. Marynowski, Shivendra V. Singh. Honokiol, a Constituent of Oriental Medicinal Herb Magnolia officinalis, Inhibits Growth of PC-3 Xenografts In vivo in Association with Apoptosis Induction. Clinical Cancer Research 2008; 14(4) doi: 10.1158/1078-0432.CCR-07-1926
|
| 99 |
Gaurav Kaushik, Anand Venugopal, Prabhu Ramamoorthy, David Standing, Dharmalingam Subramaniam, Shahid Umar, Roy A. Jensen, Shrikant Anant, Joshua M.V. Mammen. Honokiol inhibits melanoma stem cells by targeting notch signaling. Molecular Carcinogenesis 2015; 54(12) doi: 10.1002/mc.22242
|
| 100 |
Mélanie Poivre, Pierre Duez. Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents. Journal of Zhejiang University-SCIENCE B 2017; 18(3) doi: 10.1631/jzus.B1600299
|
| 101 |
Chandraiah Godugu, Ravi Doddapaneni, Mandip Singh. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC). Colloids and Surfaces B: Biointerfaces 2017; 153 doi: 10.1016/j.colsurfb.2017.01.038
|
| 102 |
Kishore Banik, Abhishek Manoj Ranaware, Vishwas Deshpande, Savita Pravin Nalawade, Ganesan Padmavathi, Devivasha Bordoloi, Bethsebie Lalduhsaki Sailo, Muthu K. Shanmugam, Lu Fan, Frank Arfuso, Gautam Sethi, Ajaikumar B. Kunnumakkara. Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets. Pharmacological Research 2019; 144 doi: 10.1016/j.phrs.2019.04.004
|
| 103 |
Dandan Liao, Yan Yang, Shuxin Xiong, Jizhou Feng, Cheng Zou, Haibo Peng, Xiaohong Yang, Shao-Lin Zhang, Zhi-Peng Wang, Yun He, Chao Huang.. Self-assembled GSH-responsive polycyclophosphazene loaded honokiol nano-drug for enhanced cancer therapy. Colloids and Surfaces B: Biointerfaces 2025; 255 doi: 10.1016/j.colsurfb.2025.114876
|
| 104 |
Su-Kyung Lee, Hye-Nan Kim, Yeong-Rim Kang, Chang Woo Lee, Hwan-Mook Kim, Dong Cho Han, Jongheon Shin, KiHwan Bae, Byoung-Mog Kwon. Obovatol inhibits colorectal cancer growth by inhibiting tumor cell proliferation and inducing apoptosis. Bioorganic & Medicinal Chemistry 2008; 16(18) doi: 10.1016/j.bmc.2008.08.033
|
| 105 |
Melissa E Munroe, Thomas R Businga, Joel N Kline, Gail A Bishop. Anti-Inflammatory Effects of the Neurotransmitter Agonist Honokiol in a Mouse Model of Allergic Asthma. The Journal of Immunology 2010; 185(9) doi: 10.4049/jimmunol.1000630
|
| 106 |
Maurizio Coppola, Raffaella Mondola. Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence. Medical Hypotheses 2014; 83(6) doi: 10.1016/j.mehy.2014.09.015
|
| 107 |
Jung Min Song, Arunkumar Anandharaj, Pramod Upadhyaya, Ameya R. Kirtane, Jong-Hyuk Kim, Kwon Ho Hong, Jayanth Panyam, Fekadu Kassie. Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors. Oncotarget 2016; 7(36) doi: 10.18632/oncotarget.10759
|